X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-05-15 | DXCM | Dolan Matthew Vincent | EVP Strategy, Corporate Dev | S - Sale | $126.58 | -2,423 | 40,075 | -6% | -$306,703 | ||||||
2024-04-15 | DXCM | Dolan Matthew Vincent | EVP Strategy, Corporate Dev | S - Sale | $137.81 | -1,990 | 42,377 | -4% | -$274,242 | ||||||
2024-03-15 | DXCM | Dolan Matthew Vincent | EVP Strategy, Corp Dev | S - Sale | $130.21 | -4,203 | 44,367 | -9% | -$547,259 | ||||||
2024-03-12 | DXCM | Dolan Matthew Vincent | EVP Strategy, Corporate | S - Sale | $134.41 | -6,710 | 48,570 | -12% | -$901,896 | ||||||
2023-09-01 | DXCM | Dolan Matthew Vincent | SVP Corporate Strategy-Develop | S - Sale | $102.32 | -56 | 33,569 | 0% | -$5,730 | ||||||
2023-03-16 | DXCM | Dolan Matthew Vincent | SVP Corporate Strategy-Develop | S - Sale | $115.00 | -2,303 | 33,569 | -6% | -$264,845 | ||||||
2023-03-13 | DXCM | Dolan Matthew Vincent | SVP Corporate Strategy-Develop | S - Sale | $106.27 | -6,229 | 35,872 | -15% | -$661,956 | ||||||
2023-03-06 | DXCM | Dolan Matthew Vincent | SVP Corporate Strategy-Develop | S - Sale | $114.40 | -226 | 26,536 | -1% | -$25,854 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |